undamentalytics Newsletter
Sign in

Corebridge Financial, Inc. (CRBG) stock

Add to watchlist

Add holding +

NYSE: CRBG NYSE Life & Health Insurance Next results ~February 1, 2027

B+ Fundamentals grade

Corebridge Financial, Inc. is a US-listed company in the life & health insurance industry. Its financial year ends in December.

Stock price today

Loading chart…

Third-party market data · may be delayed

Fair value per share

~$52

Valuation models combined (5)

Base case. Range ~$38–$58. Weighted average of 5 models (residual income, justified price-to-book, price-to-book vs return on equity (peers), forward price-to-earnings vs peers, dividend discount (two-stage)), the residual income counting double.

Price vs value

Undervalued

The price is below our entire value range; our base value is 49% above it.

Price used: $35.04, November 2, 2026

Corebridge Financial, Inc. valuation: adjust assumptions and compare models →

Who’s trading

What company insiders, investment funds and members of Congress have been doing with the stock, from their own filings.

  • Insiders1 buying, 2 selling43 purchases and 6 sales by directors and officers, last 12 monthsInsider trades
  • Funds221 adding, 219 cuttingOf 60 active managers that changed their stake, 33 added; quarter to June 30, 2026Fund buyers and sellers

Value diary

Our note on each quarter Corebridge Financial files

Where Corebridge Financial stands after its latest 10-Q

Revenue for the twelve months to June 2026 was $20.1bn, up 29.5% on a year earlier, faster than 14.5% a quarter earlier. The diluted share count is down 12.8% on a year earlier, which lifts each remaining share. Our valuation models combined value is $50.56 a share, against a share price of $34.98.

Source: 10-Q filed August 5, 2026 on SEC EDGAR · Financials · Valuation

Written from the company's filings and our models when each quarter's report arrives. Figures in older notes are as published at the time. Not investment advice.

The Fundamentalytics view

Next results ~February 1, 2027 (estimated)

Corebridge Financial, Inc.'s trailing-twelve-month revenue grew 29.5% year on year, with a free-cash-flow margin of 5.7%. Where it stands out: change in share count of -12.8% ranks 1 of 16 life & health insurance companies we cover.

Current signal Revenue growth accelerating: TTM revenue growth rose to 29.5% (+14.9pp vs the prior quarter).

Assembled from SEC-filed figures — the full workings are on this page and in our methodology. Observations, not recommendations.

Highlights

How we pick these

Strengths

  • Priced below our value. The share price of $35.04 is 49% below our value per share of $52.
  • Fast growth. Revenue grew 29.5% over the last 12 months, against a median of 7.0% for life & health insurance companies we cover.
  • Growth speeding up. The growth rate is 14.9 points higher than a quarter earlier.
  • Shrinking share count. Diluted shares fell 12.8% in a year, so each share owns more of the business.

Things to watch

  • Below peers: net margin. Net margin of 4.5% ranks 14 of 18 life & health insurance companies we cover (median 6.9%).
  • Short interest rising. Shares sold short rose 20% in a month to 5.8% of tradable shares.

Latest results: FY2026 Q2

Filed August 5, 2026
Earnings per share
$1.22 against an average estimate of $1.24: missed by 1.4%
Revenue
$3.91bn, up 43.6% on a year earlier
Share reaction
+7.3% in the first session after the results on August 4, 2026, against +1.6% for the S&P 500
Next report
November 2, 2026; average EPS estimate $1.15

Corebridge Financial's figures from its SEC filings and results release; estimates are the analysts' average. Not a recommendation.

Price chart

  • 1 day+0.7%
  • 1 week+1.1%
  • 1 month+3.0%
  • This year+19.2%
  • 1 year+11.3%
  • S&P 500 this year+11.2%

Closing prices to 2026-11-02. Price change only, dividends excluded.

Loading chart…

Third-party market data · may be delayed

At a glance

Trailing twelve months, from SEC filings

Profitability

Revenue (TTM)
$20.1B
Net margin
4.5%
EPS (TTM, diluted)
$1.84

Growth

Revenue growth
+29.5%
Change in growth rate
+14.9 pts
Share count change
−12.8%

Earnings

Last results
November 2, 2026
Next results (est.)
February 1, 2027

News & updates

Updated November 3, 2026

Company announcements, filed results and changes that matter to shareholders.

  1. Results
  2. Insider trade
  3. Insider trade
  4. Insider trade
  5. Insider trade
  6. Insider trade
  7. Insider trade
  8. Insider trade
  9. Insider trade
  10. Insider trade
  11. Insider trade
  12. Insider trade
  13. Insider trade
  14. Insider trade
  15. Announcement
  16. Insider trade
  17. Insider trade
  18. Insider trade
  19. Insider trade
  20. Results
  21. Shareholder vote
  22. Financing
  23. Results
  24. Deal
  25. Shareholder vote
  26. Announcement
  27. Announcement

Refreshed hourly when new source data is available. Summaries are checked against company releases and SEC filings. Company announcement headlines are labelled when a checked summary is unavailable.

Valuation

Corebridge Financial, Inc. valuation models and calculator

Fundamentalytics rating

model v1.6 · 2026-11-03
Buy12-month view
12-month price target
~$52
Price used
$36.08close November 3, 2026
Implied change
▲ +44%
Uncertainty
Low

How we got here: the combined value of 5 valuation models built for a business like Corebridge Financial, Inc. (see the models table below and how they are combined) , with a 9.51% cost of equity. The models span ~$38–~$58; that spread sets a 15% margin before we rate Buy or Sell.

Produced by Fundamentalytics' automated valuation model on November 3, 2026, using delayed market prices. Rating meanings, methodology and conflicts: recommendations disclosure and research disclaimer. General research, not personal advice — it does not consider your circumstances. Prices can fall as well as rise.

Valuation models

We value Corebridge Financial, Inc. as an insurer, with every model that fits that kind of business. Cost of equity 9.5%: the 10-year Treasury yield (4.9%) plus a beta of 1.01 times a 4.5% equity risk premium.

Value per share by model
Model Value per share In the combined value?
Residual income Book value plus the present value of returns above the cost of equity, fading over ten years. ~$56 ~$41–$80 Primary model, counts double
Justified price-to-book Book value times (return on equity - growth) / (cost of equity - growth): steady-state returns. ~$54 ~$47–$63 Included
Price-to-book vs return on equity (peers) The price-to-book that peers with this return on equity trade on, from a line fitted across peers. ~$50 ~$33–$66 Included
Price-to-book vs peers Book value per share times peers' typical (harmonic-mean) price-to-book. ~$0.1 ~$16–$49 Left out: out of range vs price (0.00x)
Forward price-to-earnings vs peers Next year's consensus earnings per share times peers' typical (harmonic-mean) forward price-to-earnings. Uses analysts' consensus estimates (third-party data), not our forecasts. ~$38 ~$35–$60 Included
Dividend discount (two-stage) Dividends for five years at the growth the business can fund, then a steady payout and growth. ~$58 ~$49–$71 Included
Combined value Weighted average of the models that apply: the primary model (residual income) counts double. Models more than 5x or less than 0.2x the share price, or more than 3x away from the other models' median, are left out. ~$52 ~$38–$58 5 models

Different models fail in different ways, so where several apply we average them rather than trust one. Peer-based models compare Corebridge Financial, Inc. with life and health insurers in our coverage, using third-party market data. Model values are estimates under stated assumptions, updated as new filings arrive; not price targets or investment advice. How each model works.

Moat

Not assessed: fewer than five years of comparable figures in the filings. AI disruption exposure for this industry: Medium.

A rules-based reading of reported figures, not a forecast and not investment advice. How the score is built: methodology.

Forecasts and guidance

Analysts' consensus

Fiscal yearEPSGrowthRevenueGrowth
Current $4.56 +3% $19.1bn −7%
Next $5.73 +26% $20.6bn +8%

Next year's EPS estimate has moved −0.4% in 90 days, across 16 analysts.

How the EPS forecast has moved

The consensus EPS forecast for the current fiscal year is +2.2% on 90 days ago. In the last 30 days, 6 analysts raised Corebridge Financial, Inc.'s forecast and 1 cut it.

Consensus EPS forecast Corebridge Financial, Inc., last 90 days
$4.00 $4.50 $5.00 $5.50 $6.00 90 days ago 60 days ago 30 days ago 7 days ago Now Current fiscal year, 90 days ago: $4.46 Current fiscal year, 60 days ago: $4.55 Current fiscal year, 30 days ago: $4.57 Current fiscal year, 7 days ago: $4.56 Current fiscal year, Now: $4.56 $4.56 Next fiscal year, 90 days ago: $5.75 Next fiscal year, 60 days ago: $5.77 Next fiscal year, 30 days ago: $5.78 Next fiscal year, 7 days ago: $5.73 Next fiscal year, Now: $5.73 $5.73

Average of analysts' published estimates (third-party data).

View chart data
Period Current fiscal yearNext fiscal year
90 days ago $4.46$5.75
60 days ago $4.55$5.77
30 days ago $4.57$5.78
7 days ago $4.56$5.73
Now $4.56$5.73

Earnings against estimates

Quarter toEstimateActualSurprise
Sept 2026 $1.24 $1.22 −1.4%
Jun 2026 $1.08 $1.12 +3.5%
Mar 2026 $1.03 $1.05 +1.6%
Dec 2025 $1.11 $1.22 +9.7%

Adjusted EPS as companies report it, against the average analyst estimate.

Management guidance

Earnings release, August 4, 2026

No numeric guidance in Corebridge Financial, Inc.'s latest earnings release (filed August 4, 2026). Some companies give their outlook only on the earnings call.

Analyst recommendations

14 analysts, Nov 2026
Buy1179%
Hold321%
Sell00%

Monthly trend

  1. Nov 202638314
  2. Oct 202638314
  3. Sep 202638314

Counts of recommendations published by analysts covering Corebridge Financial, Inc., by month. Source: Aggregated broker recommendations (third-party data). Aggregated counts only: we do not reproduce any firm's recommendation or price target, and these are not Fundamentalytics ratings.

Positioning

Short interest
5.8%
of tradable shares
Days to cover
2.91
at average volume
Short interest, 1 month
+20%
to October 15, 2026
Held by institutions
—
of shares
Held by insiders
0.3%
of shares
Employees
4,800
full time

Consensus figures average analysts' published estimates (third-party data); guidance is the company's own. Neither is our forecast. Short interest is reported twice a month and lags. Market data may be delayed.

This section is general information, not investment advice or a personal recommendation, and it does not take account of your objectives or circumstances. Forecasts and guidance are estimates, not promises: companies miss their own guidance and analysts' figures are often revised. Prices can fall as well as rise, and you can lose money. See our disclaimer.

Share-price performance

Market data may be delayed

What moved the share price

Last 12 months +11.3%

$31.48 on October 31, 2025 to $35.04

ThenNowEffect
Revenue (last 12 months) $15.5bn $20.1bn +29.5%
P/S multiple 1.2x 0.9x −25.0%
Share count 567m 494m +14.7%

Biggest factor: p/s multiple. Loss-making at one end, so the split uses price/sales.

Last 3 years +95.1%

$17.96 on November 3, 2023 to $35.04

ThenNowEffect
Revenue (last 12 months) $20.7bn $20.1bn −3.0%
Net margin 12.1% 4.5% −62.8%
P/E multiple 4.7x 19.1x +310.2%
Share count 651m 494m +31.7%

Biggest factor: p/e multiple.

The effects multiply back to the price change exactly. Results are the last 12 months as known on each date (filings assumed public 45 days after quarter end).

Return and risk by year

Calendar year 2023202420252026 to date
Return
CRBG+25%+43%+4%+19%
Industry peers (median)+19%+26%+11%+11%
S&P 500+26%+25%+18%+11%
Months that ended higher
CRBG67%75%58%73%
S&P 50067%75%75%46%
Largest fall from a high during the year
CRBG−33%−23%−26%−28%
S&P 500−10%−8%−19%−9%

Worst fall since September 16, 2022: 36% from July 29, 2025 to March 27, 2026. Getting back needed a 57% gain, reached on September 3, 2026, 160 days after the low.

Price behaviour

52-week range
$21.95 – $35.59
From 52-week high
−1.5%
vs 50-day average
+2.7%
vs 200-day average
+18.8%
Volatility (1 year)
35%
Beta vs S&P 500
1.30

Volatility is the annualised standard deviation of daily returns. Beta 1.5 means the shares typically moved 1.5% for each 1% move in the S&P 500 over the past year. Prices to November 2, 2026.

Share price after results

Next day
5 up, 6 down
typical move ±3.4%
After a week
4 up, 7 down
typical move ±4.9%
After a month
5 up, 6 down
typical move ±6.2%
Results releasedNext dayS&P 500 next day5 days21 days
August 4, 2026 +7.3% +1.6% +6.6% +7.1%
May 4, 2026 +3.4% +0.4% −4.3% −5.7%
April 16, 2026 −0.3% +1.5% −1.0% +2.8%
February 9, 2026 +0.9% +0.2% −0.8% −24.6%
November 3, 2025 −4.0% −1.0% −7.4% −9.2%
August 4, 2025 −0.5% +1.0% −3.3% −0.4%
May 5, 2025 +2.1% −1.4% +6.2% +6.2%
February 12, 2025 −3.4% +0.7% +1.0% −4.1%
November 4, 2024 −5.1% +1.0% −2.1% +2.6%
July 31, 2024 −6.9% +0.2% −15.9% −2.9%
May 3, 2024 +3.9% +2.3% +5.1% +2.6%

From the close before the release date to the close 1, 5 and 21 trading days after it, so releases before the open and after the close are both captured. Past moves don't predict future ones.

Options strategies

All options ideas

How Corebridge Financial, Inc.’s listed options are priced, and three ways to use them that follow from our valuation. Quotes are delayed, read November 2, 2026. Check the live chain at your broker before trading.

Cash-secured put

Not offered: no liquid put with an effective price at or below fair value.

We suggest selling a put only on well-rated companies, at a strike where the price you would pay if assigned (strike less premium) is at or below our fair value.

Covered call

Not offered: no liquid call at or above our price target — the model says the upside is worth more than any listed strike.

For holders: sell a call at a strike at or above our fair value, so the shares are only sold at a price the model calls full value.

Collar

Not offered: the shares trade below our fair value: a collar caps upside the model expects.

For holders of a stock trading at or above our fair value: buy a put for a floor and sell a call to pay for it.

General research, not personal advice. Options can lose you more than you expect and are not suitable for everyone: put sellers can be made to buy shares that keep falling, call sellers give up gains above the strike, and results or news can move prices sharply. Chances shown are approximations from each option’s delta. Spreads, fees and early assignment are not modelled.

Corebridge Financial, Inc. in five measures

Fundamentals grade B+
Growth Profitability Balance sheet Value

Growth, profitability, cash generation and balance sheet are percentiles against the companies we cover in the same industry, from SEC filings (100 = best). Value compares the share price with our modelled value range (50 = at our base value; higher = cheaper). A description of reported data and our model — not a quality score or advice.

Fundamentals

Revenue (TTM) Corebridge Financial, Inc.
$14B $16B $18B $20B $22B FY23 Q3 FY24 Q2 FY25 Q1 FY26 Q2 Revenue (TTM), FY23 Q3: $19.7B Revenue (TTM), FY23 Q4: $18.8B Revenue (TTM), FY24 Q1: $20.4B Revenue (TTM), FY24 Q2: $18.3B Revenue (TTM), FY24 Q3: $15.4B Revenue (TTM), FY24 Q4: $18.7B Revenue (TTM), FY25 Q1: $16.5B Revenue (TTM), FY25 Q2: $15.5B Revenue (TTM), FY25 Q3: $18.3B Revenue (TTM), FY25 Q4: $18.5B Revenue (TTM), FY26 Q1: $18.9B Revenue (TTM), FY26 Q2: $20.1B $20.1B

Source: SEC EDGAR filings. Retrieved October 20, 2026.

View chart data
Period Revenue (TTM)
FY23 Q3 $19.7B
FY23 Q4 $18.8B
FY24 Q1 $20.4B
FY24 Q2 $18.3B
FY24 Q3 $15.4B
FY24 Q4 $18.7B
FY25 Q1 $16.5B
FY25 Q2 $15.5B
FY25 Q3 $18.3B
FY25 Q4 $18.5B
FY26 Q1 $18.9B
FY26 Q2 $20.1B
Revenue growth, TTM YoY Corebridge Financial, Inc.
-40% -20% 0% 20% 40% FY23 Q3 FY24 Q2 FY25 Q1 FY26 Q2 Revenue growth, TTM YoY, FY23 Q3: -27.9% Revenue growth, TTM YoY, FY23 Q4: -23.9% Revenue growth, TTM YoY, FY24 Q1: -6.2% Revenue growth, TTM YoY, FY24 Q2: -11.4% Revenue growth, TTM YoY, FY24 Q3: -21.5% Revenue growth, TTM YoY, FY24 Q4: -0.3% Revenue growth, TTM YoY, FY25 Q1: -19.1% Revenue growth, TTM YoY, FY25 Q2: -15.4% Revenue growth, TTM YoY, FY25 Q3: 18.8% Revenue growth, TTM YoY, FY25 Q4: -1.4% Revenue growth, TTM YoY, FY26 Q1: 14.5% Revenue growth, TTM YoY, FY26 Q2: 29.5% 29.5%

Source: SEC EDGAR filings. Retrieved October 20, 2026.

View chart data
Period Revenue growth, TTM YoY
FY23 Q3 -27.9%
FY23 Q4 -23.9%
FY24 Q1 -6.2%
FY24 Q2 -11.4%
FY24 Q3 -21.5%
FY24 Q4 -0.3%
FY25 Q1 -19.1%
FY25 Q2 -15.4%
FY25 Q3 18.8%
FY25 Q4 -1.4%
FY26 Q1 14.5%
FY26 Q2 29.5%
FCF margin (TTM) Corebridge Financial, Inc.
0% 5% 10% 15% 20% FY23 Q3 FY24 Q2 FY25 Q1 FY26 Q2 FCF margin (TTM), FY23 Q3: 13.2% FCF margin (TTM), FY23 Q4: 15.9% FCF margin (TTM), FY24 Q1: 16.3% FCF margin (TTM), FY24 Q2: 11.7% FCF margin (TTM), FY24 Q3: 8.3% FCF margin (TTM), FY24 Q4: 10.4% FCF margin (TTM), FY25 Q1: 10.4% FCF margin (TTM), FY25 Q2: 9.0% FCF margin (TTM), FY25 Q3: 6.4% FCF margin (TTM), FY25 Q4: 7.9% FCF margin (TTM), FY26 Q1: 5.3% FCF margin (TTM), FY26 Q2: 5.7% 5.7%

Source: SEC EDGAR filings. Retrieved October 20, 2026.

View chart data
Period FCF margin (TTM)
FY23 Q3 13.2%
FY23 Q4 15.9%
FY24 Q1 16.3%
FY24 Q2 11.7%
FY24 Q3 8.3%
FY24 Q4 10.4%
FY25 Q1 10.4%
FY25 Q2 9.0%
FY25 Q3 6.4%
FY25 Q4 7.9%
FY26 Q1 5.3%
FY26 Q2 5.7%

Data: SEC EDGAR XBRL company facts (as filed in 10-K/10-Q); forms 10-K, 10-K/A, 10-Q. Generated November 3, 2026. Definitions in our methodology.

Financial statements

US$ billions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year 2020 Dec 2020 2021 Dec 2021 2022 Dec 2022 2023 Dec 2023 2024 Dec 2024 2025 Dec 2025 LTM Jun 2026
Income
Revenue 15.1 23.3 24.7 18.8 18.7 18.5 20.1
Net income 0.6 8.2 8.2 1.1 2.2 −0.4 0.9
Diluted EPS — — $12.60 $1.71 $3.72 −$0.68 $1.84
Growth (year on year)
Revenue — +54.4% +6.2% −23.9% −0.5% −1.2% +29.5%
Net income — +>999% −1.0% −86.5% +102.0% −116.4% —
Diluted EPS — — — −86.4% +117.5% −118.3% —
Margins
Net margin 4.3% 35.4% 33.0% 5.9% 11.9% −2.0% 4.5%
Cash flow
Cash from operations 3.3 2.4 2.6 3.4 2.2 2.0 1.9
Stock-based pay 0.1 0.1 0.1 0.1 0.1 0.1 —
Balance sheet
Cash 0.9 0.6 0.6 0.6 0.8 0.5 0.4
Total debt — 15.7 15.3 11.9 12.4 10.9 12.2
Net debt (negative = net cash) −0.9 15.1 14.7 11.2 11.6 10.5 11.8
Diluted shares — — 647m 645m 599m 539m 494m
Returned to shareholders
Dividends 0.0 0.0 0.9 1.7 0.5 0.5 0.5
Buybacks — 0.0 0.0 0.5 1.8 2.1 3.0
Total returned 0.0 0.0 0.9 2.2 2.3 2.6 3.5

Source: SEC EDGAR XBRL company facts (US and foreign periodic filings); column headings link to the filing. EBITDA is operating income plus depreciation and amortisation. Free cash flow is cash from operations minus capital spending. Growth is left blank when last year's figure was a loss or under 2% of revenue. Share counts and EPS are restated for stock splits. A dash means the company didn't report the figure.

Dividends, buybacks and capital spending

FY2026 Q2 TTM
Buybacks (TTM)
$3B
Dividends (TTM)
$473M
Returned to shareholders
308%
of free cash flow
Buybacks, last 3 fiscal years
$4.4B
Diluted share count
−12.8%
year over year
Total shareholder yield
22.5%
dividends 3.0% + buybacks 19.4% of market value
Dividend payout ratio
52%
of net income paid out
Sales & admin spending
9.4%
of revenue

Competitors: side by side with peers

Closest by revenue in life & health insurance
Last 12 months unless stated CRBG LNC AFL PFG ATHS UNM Median
Revenue, last 12 months $20.1bn $19.3bn $18.1bn $16.6bn $29.0bn $13.3bn $11.1bn
Revenue growth, last 12 months 29.5% 7.9% 13.6% 5.2% 45.9% 3.4% 6.1%
Revenue growth, 3-year average −1.0% 7.3% −1.0% 5.6% 8.2% 3.3% 4.9%
Revenue growth, latest quarter 43.6% 12.3% −1.0% 25.4% 70.8% 0.3% 6.9%
Operating margin — — 22.9% — — 12.3% 12.3%
Operating margin, 3-year average — — 22.2% — — 12.1% 15.0%
Net margin 4.5% 12.2% 26.9% 11.9% 2.9% 5.3% 6.5%
Cash from operations / revenue 9.2% −6.9% 14.6% 33.3% 21.8% 6.2% 14.6%
Free-cash-flow margin 5.7% — — 32.5% — 5.2% 19.4%
Free-cash-flow margin, 3-year average 8.8% — — 31.9% — 8.7% 21.3%
Stock pay / revenue — — — 0.5% 0.1% — 0.8%
Change in share count −12.8% 11.4% −5.7% −4.0% — −8.2% −4.7%

Median of all 18 companies we cover in life & health insurance. Shaded: best of the six on that line (lowest for stock pay and share-count growth). 3-year figures average the last three 12-month periods; 3-year growth is compound annual. Source: SEC filings.

Peer comparison

18 life & health insurance companies
Measure Company Peer median Rank
Revenue growth Growth 29.5% 7.0% 2 of 18
Change in growth rate Growth +14.9pp +1.5pp 3 of 18
Net margin Profitability 4.5% 6.9% 14 of 18
Change in share count Balance sheet -12.8% -4.7% 1 of 16

Rank 1 = best in the group (for spending, debt and dilution, lower ranks first).

Where the revenue comes from

Fiscal year to December 31, 2025
Geography
Region Revenue Share YoY
North America $18.5B 100.0% ▼ 0.6%
International $0 0.0% ▼ 100.0%

From Corebridge Financial, Inc.'s 10-K filed February 11, 2026, as tagged in the filing. View filing. Indented rows are part of the line above; their share is of that line. In the bars, the faint bar behind is the year before.

Who owns it

Funds buying and selling
Reported value
$14B
Institutions reporting
443
Shares held vs prior quarter
▲ 8.1%
Positions opened / closed
67 / 49

Top buyers and sellers, Q2 2026: 221 institutions bought and 219 sold ; the biggest buyer was Blackrock, Inc (+25.4M shares) and the biggest seller American International Group, Inc (−25.5M). See which funds bought and sold →

Largest reported holders, June 30, 2026
Manager Value Shares Share of 13F value Shares QoQ
Nippon Life Insurance Co $3.5B 122.0M 25.0% 0.0%
Blackstone Inc. $1.8B 62.0M 12.7% 0.0%
Pzena Investment Management LLC $967M 33.8M 6.9% ▲ 24.9%
Blackrock, Inc. $726M 25.4M 5.2% ▲ 747770.9%
Harris Associates L P $720M 25.1M 5.2% ▲ 0.7%
FMR LLC $418M 14.6M 3.0% ▲ 1759.0%
Norges Bank $407M 14.2M 2.9% —
Dimensional Fund Advisors LP $336M 11.7M 2.4% ▲ 32.2%
Hotchkis & Wiley Capital Management LLC $333M 11.6M 2.4% ▲ 28.2%
Vanguard Portfolio Management LLC $333M 11.6M 2.4% ▼ 8.9%
Vanguard Capital Management LLC $321M 11.2M 2.3% ▼ 6.6%
State Street Corp $301M 10.5M 2.2% ▼ 6.7%

From Form 13F filings with the SEC ( quarterly data sets), as reported by each manager for June 30, 2026 and filed up to 45 days later. 13F reports cover long US-listed positions of managers above $100M only, so this is not Corebridge Financial, Inc.'s complete shareholder register. Values are as reported by the filers ; 2 inconsistently scaled filing rows were excluded.

Insider trading activity

Full insider history and chart
Insider purchases History → $348M 43 trades by 1 insider, last 12 months Insider sales History → $1.6M 6 trades by 2 insiders · 84% under pre-set plans
Net ▲ $347M net buying
Insider Date Trade Shares Price Value
Nippon Life Insurance Co 10% owner October 29, 2026 Buy pre-set plan 246,521 $35.50 $8.8M
Nippon Life Insurance Co 10% owner October 28, 2026 Buy pre-set plan 245,898 $35.26 $8.7M
Nippon Life Insurance Co 10% owner October 27, 2026 Buy pre-set plan 178,129 $35.14 $6.3M
Nippon Life Insurance Co 10% owner October 26, 2026 Buy pre-set plan 182,826 $34.95 $6.4M
Nippon Life Insurance Co 10% owner October 23, 2026 Buy pre-set plan 184,093 $34.48 $6.3M
Nippon Life Insurance Co 10% owner October 23, 2026 Buy pre-set plan 411,516 $33.74 $13.9M
Nippon Life Insurance Co 10% owner October 22, 2026 Buy pre-set plan 246,440 $35.15 $8.7M
Nippon Life Insurance Co 10% owner October 21, 2026 Buy pre-set plan 217,182 $35.38 $7.7M
Nippon Life Insurance Co 10% owner October 20, 2026 Buy pre-set plan 193,357 $35.01 $6.8M
Nippon Life Insurance Co 10% owner October 19, 2026 Buy pre-set plan 162,024 $34.51 $5.6M
Nippon Life Insurance Co 10% owner October 16, 2026 Buy pre-set plan 347,195 $34.71 $12.1M
Nippon Life Insurance Co 10% owner October 15, 2026 Buy pre-set plan 26,984 $34.38 $927,675

From insiders' Form 4 filings with the SEC. Excludes awards, option exercises and shares withheld for tax. "Pre-set plan" means the filing marks the trade as made under a Rule 10b5-1 plan. See every insider trade since five years ago, on a price chart.

Earnings dates and SEC filings

Results announcements

Next expected around February 1, 2027 estimated from the company's past filing pattern, not announced

  • November 2, 2026
  • August 4, 2026
  • May 4, 2026
  • April 16, 2026
  • February 9, 2026
  • November 3, 2025

Recent SEC filings

Data status

When each part of this page on Corebridge Financial, Inc. was last updated.

DataLast updatedSource
Share priceExchange closing prices
Financial statementsSEC 10-K and 10-Q filings
News and updatesCompany releases and SEC 8-K filings
Analyst estimatesAggregated analyst estimates
Valuation and scoresOur models, from the filed figures

How we build and check these figures: methodology and data sources.

Corebridge Financial, Inc. in brief

What does Corebridge Financial, Inc. do?
Corebridge Financial, Inc. is a US-listed company in the life & health insurance industry. Its financial year ends in December.
What is Corebridge Financial, Inc.'s stock ticker?
Corebridge Financial, Inc. trades under the ticker CRBG on NYSE. This page brings together its financial statements, valuation models, ownership and recent company updates.
What is Corebridge Financial, Inc.'s revenue, and how fast is it growing?
Over its most recent trailing twelve months, Corebridge Financial, Inc. reported revenue of $20.1B, 29.5% higher than a year earlier, according to its SEC filings.
What is Corebridge Financial, Inc.'s free cash flow?
Corebridge Financial, Inc.'s free-cash-flow margin is 5.7% of revenue over the trailing twelve months.
Who are Corebridge Financial, Inc.'s largest institutional shareholders?
By value reported in 13F filings for June 30, 2026, the largest reported holders are Nippon Life Insurance Co, Blackstone Inc. and Pzena Investment Management LLC. 13F reports cover long US-listed positions of managers above $100M, filed up to 45 days after quarter end.
Is Corebridge Financial, Inc. buying back stock, and does it pay a dividend?
Corebridge Financial, Inc. spent $3B on share repurchases over the trailing twelve months, and its diluted share count fell 12.8% over the year.
What is Corebridge Financial, Inc.'s market cap?
On November 2, 2026, Corebridge Financial, Inc.'s market capitalisation was about $17.3B, with a price-to-earnings ratio of 19.1 and net debt of $11.8B. Market figures come from third-party market data and may be delayed.
Does Corebridge Financial, Inc. pay a dividend?
Yes: Corebridge Financial, Inc. paid $473M in dividends over the trailing twelve months, a dividend yield of 3.03% and a payout ratio of 52.1%.
Who are Corebridge Financial, Inc.'s competitors?
In our Life & Health Insurance peer group, the companies closest to Corebridge Financial, Inc. are Lincoln National Corp, Aflac, Principal Financial Group, Athene Holding Ltd. and Unum Group. The side-by-side comparison below sets their revenue, margins and growth against Corebridge Financial, Inc.'s.
Are insiders buying or selling Corebridge Financial, Inc. stock?
Over the last 12 months, Corebridge Financial, Inc.'s directors and officers reported 43 open-market purchases and 6 sales on Form 4. The insider trading page charts every trade.
When is Corebridge Financial, Inc.'s next earnings date?
Around February 1, 2027, estimated from the spacing of its past results announcements (8-K filings). That is an estimate, not a confirmed date — Corebridge Financial, Inc. announces its own schedule.